April 12, 2011

A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.

April 12, 2011

Pharmacy benefit manager SXC Health Solutions will acquire “substantially all” assets of Worcester, Mass.-based PBM MedMetrics Health Partners, SXC said Tuesday.

April 12, 2011

The Food and Drug Administration has approved a treatment made by Merck for treating skin cancer, Merck said Monday.

April 12, 2011

An investigational drug made by Teva Pharmaceutical Industries and Active Biotech for multiple sclerosis reduced disease relapses and prevented the progression of disability, according to late-stage clinical trial results announced Monday.

April 11, 2011

Nearly three-quarters of Americans surveyed by Deloitte said higher prices could slow their spending in the upcoming months.

April 11, 2011

Endo Pharmaceuticals will buy American Medical Systems for $2.9 billion, the drug maker said Monday.

April 11, 2011

Another generic drug maker is seeking to market its version of a popular opioid painkiller.

April 11, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating schizophrenia in adolescents.

April 11, 2011

Ansell Healthcare Products on Monday announced the release of Skyn Large following the success of Skyn, the first polyisoprene condom on the market, and due to high consumer demand for a larger Skyn product.

April 11, 2011

Mederma Skin Care scars gel and Mederma stretch marks therapy now are available in Canada at such retailers as Shoppers Drug Mart, London Drugs, Walmart and Pharma Plus, according to Merz Pharma Canada.

April 11, 2011

A drug originally developed by scientists in the Soviet Union to treat allergies and currently under investigation by Pfizer and Medivation did not yield significant results in a late-stage clinical trial of patients with Huntington disease, a disorder that leads to cognitive decline, the companies said Monday.

April 11, 2011

Pharmavite on Monday named Bill Tullis as its new EVP sales.

April 11, 2011

The Food and Drug Administration has approved an oral contraceptive made by Sandoz, the company said Friday.

April 11, 2011

Genzyme now officially is a wholly owned subsidiary of Sanofi-Aventis.

April 11, 2011

Winn-Dixie on Monday announced that its pharmacy will offer specially designed medication disposal envelopes to help its customers safely dispose of unused, outdated or unwanted medications.

April 8, 2011

Specialty pharmacy provider Assured Pharmacy will reduce its stock through a reverse stock split, the company said Thursday.

April 8, 2011

The Emerson Group announced that former Actavis executive Brad Blake has joined the company.

April 8, 2011

The Department of Health and Human Services on Friday launched two plans aimed at reducing health disparities.

April 8, 2011

The Food and Drug Administration has granted tentative approval to a generic antibiotic made by Hi-Tech Pharmacal, the drug maker said Friday.

April 8, 2011

Impax Labs will collaborate with a specialty pharmaceutical company dedicated to the research, development and manufacturing of unique gelatin-based dosage forms.

April 8, 2011

A Georgetown University Health Policy Institute study of Florida’s Medicaid Managed Care pilot program should raise doubts for states considering the use of for-profit managed care companies to reduce Medicaid costs, the National Community Pharmacists Association cautioned on Friday.

April 8, 2011

Danish drug maker Novo Nordisk has received the Corporate Leadership Award from the National Hemophilia Foundation in response to its research and development efforts for the disease, the company said Friday.

April 8, 2011

Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

April 8, 2011

Nine people died in Alabama last month after taking a compounded injectable supplement contaminated with bacteria, according to published reports.